APT Medical Inc - Asset Resilience Ratio

Latest as of March 2026: 8.63%

APT Medical Inc (688617) has an Asset Resilience Ratio of 8.63% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See APT Medical Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥296.01 Million
≈ $43.32 Million USD Cash + Short-term Investments

Total Assets

CN¥3.43 Billion
≈ $501.99 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how APT Medical Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is APT Medical Inc's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down APT Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read APT Medical Inc debt and liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥296.01 Million 8.63%
Total Liquid Assets CN¥296.01 Million 8.63%

Asset Resilience Insights

  • Limited Liquidity: APT Medical Inc maintains only 8.63% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

APT Medical Inc Industry Peers by Asset Resilience Ratio

Compare APT Medical Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Eurobio Scientific SA
PA:ALERS
Medical Devices 10.52%
Profound Medical Corp
TO:PRN
Medical Devices 67.66%
EBR Systems Inc
AU:EBR
Medical Devices 54.70%
Epitomee Medical Ltd
TA:EPIT
Medical Devices 0.24%
Cleo Diagnostics Ltd
AU:COV
Medical Devices 94.64%
Aligned Genetics Inc
KQ:238120
Medical Devices 2.22%

Annual Asset Resilience Ratio for APT Medical Inc (2021–2025)

The table below shows the annual Asset Resilience Ratio data for APT Medical Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 6.85% CN¥250.49 Million
≈ $36.65 Million
CN¥3.66 Billion
≈ $534.88 Million
+4.52pp
2023-12-31 2.33% CN¥60.00 Million
≈ $8.78 Million
CN¥2.57 Billion
≈ $376.51 Million
-37.26pp
2022-12-31 39.59% CN¥881.34 Million
≈ $128.97 Million
CN¥2.23 Billion
≈ $325.73 Million
-5.80pp
2021-12-31 45.39% CN¥913.72 Million
≈ $133.71 Million
CN¥2.01 Billion
≈ $294.58 Million
--
pp = percentage points

About APT Medical Inc

SHG:688617 China Medical Devices
Market Cap
$5.04 Billion
CN¥34.45 Billion CNY
Market Cap Rank
#3571 Global
#496 in China
Share Price
CN¥243.42
Change (1 day)
-0.03%
52-Week Range
CN¥181.27 - CN¥331.86
All Time High
CN¥453.00
About

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagno… Read more